PARAMETRIC PORTFOLIO ASSOCIATES LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.8%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$4,314,000
+257.1%
125,235
+73.2%
0.00%
+200.0%
Q2 2020$1,208,000
+46.2%
72,311
+26.2%
0.00%0.0%
Q1 2020$826,000
-73.2%
57,308
-37.9%
0.00%
-50.0%
Q4 2019$3,087,000
+76.0%
92,232
+10.1%
0.00%
+100.0%
Q3 2019$1,754,000
+59.7%
83,778
+58.9%
0.00%0.0%
Q2 2019$1,098,000
+33.4%
52,738
+43.3%
0.00%0.0%
Q1 2019$823,000
+20.5%
36,802
+28.9%
0.00%0.0%
Q4 2018$683,000
-9.4%
28,551
+3.4%
0.00%0.0%
Q3 2018$754,000
-14.8%
27,623
-16.0%
0.00%0.0%
Q2 2018$885,000
-4.1%
32,900
+13.4%
0.00%0.0%
Q1 2018$923,000
-27.1%
29,000
-13.4%
0.00%0.0%
Q4 2017$1,266,000
+63.8%
33,476
+7.4%
0.00%0.0%
Q3 2017$773,000
+34.2%
31,183
+11.3%
0.00%0.0%
Q2 2017$576,000
-39.4%
28,007
-35.9%
0.00%0.0%
Q1 2017$950,000
-36.6%
43,720
-40.3%
0.00%
-50.0%
Q4 2016$1,499,000
+105.9%
73,279
+50.9%
0.00%
+100.0%
Q3 2016$728,000
+39.5%
48,546
+0.6%
0.00%0.0%
Q2 2016$522,000
-1.5%
48,270
+23.4%
0.00%0.0%
Q1 2016$530,000
+76.7%
39,114
+140.3%
0.00%0.0%
Q4 2015$300,00016,2770.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders